SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3j4p'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EKJ_B_CUB4_0 (BETA-CARBONIC ANHYDRASE)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 6	CYH A 363 ARG A 288 CYH A 291 PRO A 366	None	1.48A	1ekjA-3j4pA: 0.0 1ekjB-3j4pA: 0.0	1ekjA-3j4pA: 18.33 1ekjB-3j4pA: 18.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_W_CHDW4060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.86A	1v54N-3j4pA: undetectable 1v54W-3j4pA: undetectable	1v54N-3j4pA: 22.36 1v54W-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_J_CHDJ3060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.88A	1v55A-3j4pA: undetectable 1v55J-3j4pA: undetectable	1v55A-3j4pA: 22.36 1v55J-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_W_CHDW4060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.86A	1v55N-3j4pA: undetectable 1v55W-3j4pA: undetectable	1v55N-3j4pA: 22.36 1v55W-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1WG8_B_SAMB3141_0 (PREDICTED S-ADENOSYLMETHIONINE -DEPENDENT METHYLTRANSFERASE)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	5 / 12	THR A 562 GLY A 540 GLY A 522 SER A 527 HIS A 528	None	1.21A	1wg8B-3j4pA: undetectable	1wg8B-3j4pA: 20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.87A	2dyrN-3j4pA: undetectable 2dyrW-3j4pA: undetectable	2dyrN-3j4pA: 22.36 2dyrW-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.86A	2eijN-3j4pA: undetectable 2eijW-3j4pA: undetectable	2eijN-3j4pA: 22.36 2eijW-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.86A	2eikN-3j4pA: undetectable 2eikW-3j4pA: undetectable	2eikN-3j4pA: 22.36 2eikW-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.90A	2einA-3j4pA: undetectable 2einJ-3j4pA: undetectable	2einA-3j4pA: 22.36 2einJ-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ITZ_A_IREA2021_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	3 / 3	LEU A 649 LEU A 405 MET A 404	None	0.76A	2itzA-3j4pA: undetectable	2itzA-3j4pA: 19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.82A	3abkA-3j4pA: undetectable 3abkJ-3j4pA: undetectable	3abkA-3j4pA: 22.36 3abkJ-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.95A	3ablA-3j4pA: undetectable 3ablJ-3j4pA: undetectable	3ablA-3j4pA: 22.36 3ablJ-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.84A	3abmN-3j4pA: undetectable 3abmW-3j4pA: undetectable	3abmN-3j4pA: 22.36 3abmW-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.93A	3ag3A-3j4pA: undetectable 3ag3J-3j4pA: undetectable	3ag3A-3j4pA: 22.36 3ag3J-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASO_W_CHDW1059_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.82A	3asoN-3j4pA: undetectable 3asoW-3j4pA: undetectable	3asoN-3j4pA: 22.36 3asoW-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_A_486A3_1 (GLUCOCORTICOID RECEPTOR)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	5 / 12	GLY A 678 GLN A 679 VAL A 680 LEU A 405 ILE A 650	None	1.19A	3h52A-3j4pA: undetectable	3h52A-3j4pA: 17.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U3E_A_ACTA705_0 (RIBONUCLEOSIDE TRIPHOSPHATE REDUCTASE)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 4	HIS A 360 ASP A 285 TYR A 283 VAL A 355	None	1.45A	4u3eA-3j4pA: 0.0	4u3eA-3j4pA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Y_A_EF2A151_1 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.46A	4v2yA-3j4pA: 0.0	4v2yA-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Y_B_EF2B151_1 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.45A	4v2yB-3j4pA: undetectable	4v2yB-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Z_A_Y70A151_1 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.47A	4v2zA-3j4pA: undetectable	4v2zA-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Z_B_Y70B151_1 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.42A	4v2zB-3j4pA: undetectable	4v2zB-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V30_A_LVYA151_1 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.47A	4v30A-3j4pA: undetectable	4v30A-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V30_B_LVYB151_1 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.37A	4v30B-3j4pA: undetectable	4v30B-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XT7_A_TOPA302_1 (RV2671)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	5 / 11	ILE A 260 THR A 279 SER A 278 GLY A 378 THR A 264	None	1.17A	4xt7A-3j4pA: undetectable	4xt7A-3j4pA: 19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4G_A_IPHA903_0 (PROTEIN ARGONAUTE-2)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 6	LEU A 352 TYR A 354 PRO A 353 TYR A 377	None	1.31A	4z4gA-3j4pA: undetectable	4z4gA-3j4pA: 18.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMH_A_EF2A151_1 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.50A	5amhA-3j4pA: undetectable	5amhA-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMI_A_EF2A151_1 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.46A	5amiA-3j4pA: undetectable	5amiA-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMJ_A_EF2A151_1 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.46A	5amjA-3j4pA: undetectable	5amjA-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMJ_B_EF2B151_1 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.43A	5amjB-3j4pA: undetectable	5amjB-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.79A	5b1bA-3j4pA: undetectable 5b1bJ-3j4pA: undetectable	5b1bA-3j4pA: 22.36 5b1bJ-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.82A	5iy5A-3j4pA: undetectable 5iy5J-3j4pA: undetectable	5iy5A-3j4pA: 22.36 5iy5J-3j4pA: 9.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_A_EF2A202_0 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.48A	5oh1A-3j4pA: 0.0	5oh1A-3j4pA: 10.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_B_EF2B202_0 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.40A	5oh1B-3j4pA: undetectable	5oh1B-3j4pA: 10.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH3_A_9V2A202_0 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.45A	5oh3A-3j4pA: undetectable	5oh3A-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH3_B_9V2B202_0 (CEREBLON ISOFORM 4)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	PRO A 310 PHE A 639 TRP A 620 TYR A 354	None	1.43A	5oh3B-3j4pA: undetectable	5oh3B-3j4pA: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 7	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.86A	5xdqN-3j4pA: undetectable 5xdqW-3j4pA: undetectable	5xdqN-3j4pA: 22.36 5xdqW-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.87A	5xdxN-3j4pA: undetectable 5xdxW-3j4pA: undetectable	5xdxN-3j4pA: 22.36 5xdxW-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XOO_A_ADNA506_1 (GLYCOSAMINOGLYCAN XYLOSYLKINASE)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 6	TYR A 277 LEU A 352 GLU A 398 LEU A 397	None	1.23A	5xooA-3j4pA: undetectable	5xooA-3j4pA: 9.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.83A	5zcpN-3j4pA: undetectable 5zcpW-3j4pA: undetectable	5zcpN-3j4pA: 22.36 5zcpW-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	4 / 8	ILE A 374 LEU A 249 ARG A 245 LEU A 317	None	0.83A	5zcqN-3j4pA: undetectable 5zcqW-3j4pA: undetectable	5zcqN-3j4pA: 22.36 5zcqW-3j4pA: 9.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWD_C_GLYC713_0 (DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1)	3j4p	CAPSID PROTEIN VP1 (Adeno-associated virus)	3 / 3	GLN A 299 TYR A 702 ASN A 303	None	1.05A	6dwdC-3j4pA: undetectable	6dwdC-3j4pA: 21.78

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1EKJ_B_CUB4_0","BETA-CARBONIC ANHYDRASE","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"CYH A 363;ARG A 288;CYH A 291;PRO A 366","None","1.48A","1ekjA-3j4pA:0.0;1ekjB-3j4pA:0.0","1ekjA-3j4pA:18.33;1ekjB-3j4pA:18.33"],["1V54_W_CHDW4060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.86A","1v54N-3j4pA:undetectable;1v54W-3j4pA:undetectable","1v54N-3j4pA:22.36;1v54W-3j4pA:9.28"],["1V55_J_CHDJ3060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.88A","1v55A-3j4pA:undetectable;1v55J-3j4pA:undetectable","1v55A-3j4pA:22.36;1v55J-3j4pA:9.28"],["1V55_W_CHDW4060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.86A","1v55N-3j4pA:undetectable;1v55W-3j4pA:undetectable","1v55N-3j4pA:22.36;1v55W-3j4pA:9.28"],["1WG8_B_SAMB3141_0","PREDICTED S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASE","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",5,"THR A 562;GLY A 540;GLY A 522;SER A 527;HIS A 528","None","1.21A","1wg8B-3j4pA:undetectable","1wg8B-3j4pA:20.45"],["2DYR_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.87A","2dyrN-3j4pA:undetectable;2dyrW-3j4pA:undetectable","2dyrN-3j4pA:22.36;2dyrW-3j4pA:9.28"],["2EIJ_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.86A","2eijN-3j4pA:undetectable;2eijW-3j4pA:undetectable","2eijN-3j4pA:22.36;2eijW-3j4pA:9.28"],["2EIK_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.86A","2eikN-3j4pA:undetectable;2eikW-3j4pA:undetectable","2eikN-3j4pA:22.36;2eikW-3j4pA:9.28"],["2EIN_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.90A","2einA-3j4pA:undetectable;2einJ-3j4pA:undetectable","2einA-3j4pA:22.36;2einJ-3j4pA:9.28"],["2ITZ_A_IREA2021_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",3,"LEU A 649;LEU A 405;MET A 404","None","0.76A","2itzA-3j4pA:undetectable","2itzA-3j4pA:19.49"],["3ABK_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.82A","3abkA-3j4pA:undetectable;3abkJ-3j4pA:undetectable","3abkA-3j4pA:22.36;3abkJ-3j4pA:9.28"],["3ABL_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.95A","3ablA-3j4pA:undetectable;3ablJ-3j4pA:undetectable","3ablA-3j4pA:22.36;3ablJ-3j4pA:9.28"],["3ABM_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.84A","3abmN-3j4pA:undetectable;3abmW-3j4pA:undetectable","3abmN-3j4pA:22.36;3abmW-3j4pA:9.28"],["3AG3_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.93A","3ag3A-3j4pA:undetectable;3ag3J-3j4pA:undetectable","3ag3A-3j4pA:22.36;3ag3J-3j4pA:9.28"],["3ASO_W_CHDW1059_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.82A","3asoN-3j4pA:undetectable;3asoW-3j4pA:undetectable","3asoN-3j4pA:22.36;3asoW-3j4pA:9.28"],["3H52_A_486A3_1","GLUCOCORTICOID RECEPTOR","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",5,"GLY A 678;GLN A 679;VAL A 680;LEU A 405;ILE A 650","None","1.19A","3h52A-3j4pA:undetectable","3h52A-3j4pA:17.81"],["4U3E_A_ACTA705_0","RIBONUCLEOSIDE TRIPHOSPHATE REDUCTASE","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"HIS A 360;ASP A 285;TYR A 283;VAL A 355","None","1.45A","4u3eA-3j4pA:0.0","4u3eA-3j4pA:21.50"],["4V2Y_A_EF2A151_1","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.46A","4v2yA-3j4pA:0.0","4v2yA-3j4pA:14.60"],["4V2Y_B_EF2B151_1","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.45A","4v2yB-3j4pA:undetectable","4v2yB-3j4pA:14.60"],["4V2Z_A_Y70A151_1","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.47A","4v2zA-3j4pA:undetectable","4v2zA-3j4pA:14.60"],["4V2Z_B_Y70B151_1","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.42A","4v2zB-3j4pA:undetectable","4v2zB-3j4pA:14.60"],["4V30_A_LVYA151_1","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.47A","4v30A-3j4pA:undetectable","4v30A-3j4pA:14.60"],["4V30_B_LVYB151_1","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.37A","4v30B-3j4pA:undetectable","4v30B-3j4pA:14.60"],["4XT7_A_TOPA302_1","RV2671","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",5,"ILE A 260;THR A 279;SER A 278;GLY A 378;THR A 264","None","1.17A","4xt7A-3j4pA:undetectable","4xt7A-3j4pA:19.01"],["4Z4G_A_IPHA903_0","PROTEIN ARGONAUTE-2","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"LEU A 352;TYR A 354;PRO A 353;TYR A 377","None","1.31A","4z4gA-3j4pA:undetectable","4z4gA-3j4pA:18.71"],["5AMH_A_EF2A151_1","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.50A","5amhA-3j4pA:undetectable","5amhA-3j4pA:14.60"],["5AMI_A_EF2A151_1","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.46A","5amiA-3j4pA:undetectable","5amiA-3j4pA:14.60"],["5AMJ_A_EF2A151_1","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.46A","5amjA-3j4pA:undetectable","5amjA-3j4pA:14.60"],["5AMJ_B_EF2B151_1","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.43A","5amjB-3j4pA:undetectable","5amjB-3j4pA:14.60"],["5B1B_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.79A","5b1bA-3j4pA:undetectable;5b1bJ-3j4pA:undetectable","5b1bA-3j4pA:22.36;5b1bJ-3j4pA:9.28"],["5IY5_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.82A","5iy5A-3j4pA:undetectable;5iy5J-3j4pA:undetectable","5iy5A-3j4pA:22.36;5iy5J-3j4pA:9.24"],["5OH1_A_EF2A202_0","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.48A","5oh1A-3j4pA:0.0","5oh1A-3j4pA:10.71"],["5OH1_B_EF2B202_0","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.40A","5oh1B-3j4pA:undetectable","5oh1B-3j4pA:10.71"],["5OH3_A_9V2A202_0","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.45A","5oh3A-3j4pA:undetectable","5oh3A-3j4pA:14.60"],["5OH3_B_9V2B202_0","CEREBLON ISOFORM 4","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"PRO A 310;PHE A 639;TRP A 620;TYR A 354","None","1.43A","5oh3B-3j4pA:undetectable","5oh3B-3j4pA:14.60"],["5XDQ_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.86A","5xdqN-3j4pA:undetectable;5xdqW-3j4pA:undetectable","5xdqN-3j4pA:22.36;5xdqW-3j4pA:9.28"],["5XDX_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.87A","5xdxN-3j4pA:undetectable;5xdxW-3j4pA:undetectable","5xdxN-3j4pA:22.36;5xdxW-3j4pA:9.28"],["5XOO_A_ADNA506_1","GLYCOSAMINOGLYCAN XYLOSYLKINASE","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"TYR A 277;LEU A 352;GLU A 398;LEU A 397","None","1.23A","5xooA-3j4pA:undetectable","5xooA-3j4pA:9.68"],["5ZCP_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.83A","5zcpN-3j4pA:undetectable;5zcpW-3j4pA:undetectable","5zcpN-3j4pA:22.36;5zcpW-3j4pA:9.28"],["5ZCQ_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",4,"ILE A 374;LEU A 249;ARG A 245;LEU A 317","None","0.83A","5zcqN-3j4pA:undetectable;5zcqW-3j4pA:undetectable","5zcqN-3j4pA:22.36;5zcqW-3j4pA:9.28"],["6DWD_C_GLYC713_0","DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE SAMHD1","3j4p","CAPSID PROTEIN VP1","Adeno-associated virus",3,"GLN A 299;TYR A 702;ASN A 303","None","1.05A","6dwdC-3j4pA:undetectable","6dwdC-3j4pA:21.78"]]